- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate Cancer and Bone: The Elective Affinities
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2014-05-29
DOI
10.1155/2014/167035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing Prostate Cancer
- (2015) N. Patrick McCabe et al. NEOPLASIA
- Wnt and the Wnt signaling pathway in bone development and disease
- (2014) Yiping Wang Frontiers in Bioscience-Landmark
- Secreted frizzled related proteins: Implications in cancers
- (2013) Rohit Surana et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3
- (2013) J P Dijksterhuis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mesenchymal CD44 Expression Contributes to the Acquisition of an Activated Fibroblast Phenotype via TWIST Activation in the Tumor Microenvironment
- (2013) E. L. Spaeth et al. CANCER RESEARCH
- Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment
- (2013) Sandy R. Larson et al. CLINICAL & EXPERIMENTAL METASTASIS
- Wnt signaling in stem and cancer stem cells
- (2013) Jane D Holland et al. CURRENT OPINION IN CELL BIOLOGY
- TGF-β Effects on Prostate Cancer Cell Migration and Invasion Are Mediated by PGE2through Activation of PI3K/AKT/mTOR Pathway
- (2013) BaoHan T. Vo et al. ENDOCRINOLOGY
- Toxicities Following Treatment with Bisphosphonates and Receptor Activator of Nuclear Factor-κB Ligand Inhibitors in Patients with Advanced Prostate Cancer
- (2013) Benjamin A. Gartrell et al. EUROPEAN UROLOGY
- Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer
- (2013) Dali Zheng et al. MOLECULAR CANCER RESEARCH
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases
- (2013) Sandy R. Larson et al. PROSTATE
- Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
- (2013) Roger von Moos et al. SUPPORTIVE CARE IN CANCER
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
- Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells
- (2012) Eric Darrington et al. ASIAN JOURNAL OF ANDROLOGY
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways
- (2012) E.R. Gimba et al. CANCER LETTERS
- An overview of the regulation of bone remodelling at the cellular level
- (2012) Jasreen Kular et al. CLINICAL BIOCHEMISTRY
- Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
- (2012) D. G. Branstetter et al. CLINICAL CANCER RESEARCH
- Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
- (2012) Cinzia Borghese et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
- (2012) Eric Orwoll et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Loss of TGF- Responsiveness in Prostate Stromal Cells Alters Chemokine Levels and Facilitates the Development of Mixed Osteoblastic/Osteolytic Bone Lesions
- (2012) X. Li et al. MOLECULAR CANCER RESEARCH
- In SilicoDiscovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer
- (2012) Howard C. Shen et al. MOLECULAR ENDOCRINOLOGY
- The contribution of bone to whole-organism physiology
- (2012) Gérard Karsenty et al. NATURE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the endothelin axis and its antagonists in the treatment of cancer
- (2011) A Bagnato et al. BRITISH JOURNAL OF PHARMACOLOGY
- Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential
- (2011) V. Fritz et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line
- (2011) Sweta Mishra et al. PROSTATE
- Pathogenesis of osteoblastic bone metastases from prostate cancer
- (2010) Toni Ibrahim et al. CANCER
- Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells
- (2010) Antonella De Luca et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Mitf Induction by RANKL Is Critical for Osteoclastogenesis
- (2010) Ssu-Yi Lu et al. MOLECULAR BIOLOGY OF THE CELL
- Bone-marker levels in patients with prostate cancer: potential correlations with outcomes
- (2010) Fred Saad et al. Current Opinion in Supportive and Palliative Care
- Bone Marrow-Derived Cathepsin K Cleaves SPARC in Bone Metastasis
- (2009) Izabela Podgorski et al. AMERICAN JOURNAL OF PATHOLOGY
- Characterization of SV-40 Tag rats as a model to study prostate cancer
- (2009) Curt E Harper et al. BMC CANCER
- Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis
- (2009) D. Chanda et al. CLINICAL CANCER RESEARCH
- Targeting ERBB Receptors to Inhibit Metastasis: Old Hopes and New Certainties
- (2009) Adriano Angelucci CURRENT CANCER DRUG TARGETS
- Bone sialoprotein stimulates focal adhesion-related signaling pathways: Role in migration and survival of breast and prostate cancer cells
- (2009) Jonathan A.R. Gordon et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
- (2009) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
- (2009) J Akech et al. ONCOGENE
- Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid
- (2009) Michael Lein et al. PROSTATE
- Tumor–stroma co-evolution in prostate cancer progression and metastasis
- (2009) Sajni Josson et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- TGF-β signalling-related markers in cancer patients with bone metastasis
- (2008) Jose Baselga et al. BIOMARKERS
- Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases
- (2008) Hind T. Hatoum et al. CANCER
- Biochemical Markers for Monitoring Response to Therapy: Evidence for Higher Bone Specificity by a Novel Marker Compared with Routine Markers
- (2008) D. J. Leeming et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling
- (2008) Ling Qiao et al. CANCER LETTERS
- Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis
- (2008) S.-Y. Sung et al. CANCER RESEARCH
- The use of molecular markers of bone turnover in the management of patients with metastatic bone disease
- (2008) Markus J. Seibel CLINICAL ENDOCRINOLOGY
- Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells
- (2008) A. Angelucci et al. ENDOCRINE-RELATED CANCER
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases
- (2008) Martine P. Roudier et al. JOURNAL OF UROLOGY
- Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
- (2008) X Li et al. ONCOGENE
- Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis
- (2008) Christopher L. Hall et al. PROSTATE
- Transforming Growth Factor-β1 Attenuates Expression of Both the Progesterone Receptor and Dickkopf in Differentiated Human Endometrial Stromal Cells
- (2007) Nicole Kane et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now